Product Images Nitroglycerin

This is a medication information sheet for Nitroglycerin Sublingual Tablets. Each tablet contains 0.3 mg of nitroglycerin. It warns about the possibility of feeling a burning sensation at the site of tablet placement. The instruction is to store it at controlled room temperature, and to keep the tablets out of the reach of children. It also advises to seek prompt medical attention if the pain persists or is different than what was typically experienced after using up to 3 tablets over 15 minutes. The tablets should not be crushed, chewed, or swallowed. The manufacturer is Advagen Pharma Limited and it is distributed in the USA.*

This is a medication description of Nitroglycerin Sublingual Tablets. The tablets contain 0.3mg nitroglycerin and are not meant to be crushed, chewed, or swallowed. The prescription information should be consulted for dosage and use. The tablets should be kept in the original container and kept out of reach of children. The medication guide can be printed online, and the tablets should be stored at controlled room temperature. This medication is available in a pack of 100 sublingual tablets. The medication is distributed by Advagen Pharma Limited in NJ, USA, and manufactured by Rubicon Research Pvt Ltd in India.*

Each tablet contains 0.4 mg nitroglycerin. This medication guide contains the dosage and usage information. It's important to keep this and all drugs out of the reach of children. Nitroglycerin Sublingual Tablets should not be crushed, chewed or swallowed. Store at Controlled Room Temperature 20° to 25°C (68° to 77°F). Furthermore, this medicine must be kept in its original container. The printed medication guide is available at the provided website. The drug is distributed by Advagen Pharma Limited based in Plainsboro USA. It's manufactured by Rubicon Research Private Limited based in Ambernath, India.*

This text describes a medication called Nitroglycerin Sublingual Tablets, USP. The tablets are 0.4 mg each and should not be crushed, chewed, or swallowed. The medication guide provides information on dosage, usage, and storage advice to avoid losing its potency. The text also has the manufacturer's and distributor's name and address, and the NDC number for identification. Lastly, it includes a warning to keep the drug out of the reach of children and take prompt medical attention if the pain persists following the medication.*

Each tablet of Nitroglycerin Sublingual Tablets contains 0.4mg of nitroglycerin. The dosage and use information can be found in the accompanying prescribing information. These tablets should be kept out of reach of children and stored in the original container at controlled room temperature. The tablets should not be crushed, chewed or swallowed. Dispense with a patient package insert. Printed medication guide and additional details can be found on the website of Advagen Pharma's. NDC number is 72888-139-01. Manufactured by Rubicon Research Private Limited, Ambernath, Dist. Thane, 421506 India.*

Nitroglycerin Sublingual Tablets USP with 0.6 mg/tablet is available in a pack of 100 sublingual tablets. Each tablet must not be crushed, chewed, or swallowed and should be kept in the original container. A patient package insert must always be dispensed and prompt medical attention is recommended if the pain after a total of 3 tablets in a 15-minute period persists or is different from the usual experience. The tablets must be stored at controlled room temperature ranging from 20° to 25°C. A warning is indicated to close the container tightly after each use to prevent loss of potency.*

Each tablet of Nitroglycerin Sublingual Tablets contains 0.6mg nitroglycerin. The medication guide is available at www.advagenpharma.com/medguide/nitroglycerinsublingualtablets. It must be kept out of reach of children, stored at temperatures between 20° to 25°C (68° to 77°F) and in the original container. The tablets should not be crushed, chewed or swallowed. Close tightly immediately after use to prevent loss of potency. The package includes 100 sublingual tablets to be dispersed with a patient package insert. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The manufacturing license number is KD-682.*